In a groundbreaking verdict that could reshape pharmaceutical antitrust litigation, a U.S. jury has found Japanese pharmaceutical giant Takeda liable…
Read More

In a groundbreaking verdict that could reshape pharmaceutical antitrust litigation, a U.S. jury has found Japanese pharmaceutical giant Takeda liable…
Read More
Regeneron Pharmaceuticals has announced a monumental research collaboration with Parabilis Medicines, a deal valued at an impressive $2.32 billion. This…
Read More
The mystery of why the vast majority of the human population favors the right hand has remained one of the…
Read More
A pioneering research project led by the Wellcome Sanger Institute has fundamentally altered the scientific understanding of chronic myeloid leukemia…
Read More
Findings from the pivotal Phase III SURMOUNT-MAINTAIN trial, presented at the 33rd European Congress on Obesity (ECO) in Istanbul, Türkiye,…
Read More
A groundbreaking study led by researchers at McGill University and the Douglas Research Centre has unveiled specific cellular abnormalities in…
Read More
The European Union (EU) has achieved a significant legislative milestone with the provisional agreement on the Critical Medicines Act (CMA),…
Read More
Bristol Myers Squibb (BMS) and Chinese biopharmaceutical giant Hengrui Pharma have announced a monumental licensing and collaboration agreement, potentially valued…
Read More
The US Food and Drug Administration (FDA) has unveiled its comprehensive final guidance for industry on collecting crucial post-marketing safety…
Read More
The field of statistical physics has reached a transformative milestone as researchers at the University of Würzburg, in collaboration with…
Read More